Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8IXN7

Entry ID Method Resolution Chain Position Source
AF-Q8IXN7-F1 Predicted AlphaFoldDB

265 variants for Q8IXN7

Variant ID(s) Position Change Description Diseaes Association Provenance
CA339931310
rs1416210567
3 S>F No ClinGen
TOPMed
CA799328
rs764219791
4 Q>R No ClinGen
ExAC
gnomAD
rs1327300135
CA339931357
7 F>L No ClinGen
gnomAD
rs183454942
CA21211248
14 R>H No ClinGen
1000Genomes
TOPMed
gnomAD
CA339931416
rs1403576761
14 R>S No ClinGen
TOPMed
CA339931437
rs1272647825
15 E>D No ClinGen
TOPMed
gnomAD
CA339931489
rs1249136641
20 V>A No ClinGen
TOPMed
CA21211261
rs912251721
20 V>L No ClinGen
TOPMed
gnomAD
rs1363713685
CA339931506
22 I>F No ClinGen
gnomAD
CA339931546
rs1272410284
27 R>P No ClinGen
gnomAD
rs942735335
CA21211276
27 R>W No ClinGen
Ensembl
CA339931556
rs1272797913
28 Q>P No ClinGen
TOPMed
gnomAD
CA339931578
rs1570310650
30 C>S No ClinGen
Ensembl
TCGA novel 31 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1216044900
CA339931629
33 Q>H No ClinGen
TOPMed
gnomAD
rs376719599
CA799330
34 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA339931658
rs1468038701
35 V>M No ClinGen
TOPMed
gnomAD
rs535540923
CA21211298
41 L>R No ClinGen
1000Genomes
TOPMed
gnomAD
CA339931778
rs1451188363
41 L>V No ClinGen
TOPMed
CA339931860
rs1160439972
45 I>V No ClinGen
TOPMed
rs1457018577
CA339931881
46 A>S No ClinGen
TOPMed
CA339932040
rs1164590689
54 L>V No ClinGen
TOPMed
rs886609584
CA21225795
56 L>F No ClinGen
TOPMed
gnomAD
CA799343
rs772560837
60 Q>* No ClinGen
ExAC
gnomAD
rs1040663547
CA21225814
62 A>S No ClinGen
TOPMed
gnomAD
CA339934000
rs1040663547
62 A>T No ClinGen
TOPMed
gnomAD
rs1355347065
CA339934007
62 A>V No ClinGen
TOPMed
gnomAD
rs1281803479
CA339934051
66 F>C No ClinGen
gnomAD
rs761185499
CA799345
67 P>L No ClinGen
ExAC
gnomAD
CA339934078
rs1284074877
68 D>N No ClinGen
gnomAD
TCGA novel 70 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA799347
rs138538645
71 L>I No ClinGen
ESP
ExAC
gnomAD
rs138538645
CA21225846
71 L>V No ClinGen
ESP
ExAC
gnomAD
CA339934128
rs190666946
72 V>I No ClinGen
1000Genomes
ExAC
gnomAD
rs190666946
CA799348
72 V>L No ClinGen
1000Genomes
ExAC
gnomAD
CA339934140
rs1185284372
73 R>P No ClinGen
TOPMed
gnomAD
CA339934139
rs1185284372
73 R>Q No ClinGen
TOPMed
gnomAD
rs765489551
CA799349
73 R>W No ClinGen
ExAC
gnomAD
rs1234540029
CA339934143
74 V>I No ClinGen
gnomAD
rs1292212671
CA339934188
78 S>L No ClinGen
TOPMed
gnomAD
rs113498116
CA21225877
80 Q>R No ClinGen
Ensembl
rs1157590409
CA339934214
81 S>A No ClinGen
gnomAD
rs766107532
CA339934263
85 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA339934265
rs1356518475
85 I>N No ClinGen
TOPMed
rs766107532
CA799352
85 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1174626236
CA339934291
87 V>L No ClinGen
gnomAD
CA339934312
rs780592194
89 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs745357277
CA21225917
89 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA339934372
rs1279918270
94 L>Q No ClinGen
gnomAD
rs1319848280
CA339934377
95 G>S No ClinGen
TOPMed
rs1275016299
CA339934405
97 R>Q No ClinGen
gnomAD
rs201880930
CA799359
97 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 98 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs527886509
CA799360
99 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA799362
rs775856351
100 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA799363
rs747498612
101 R>C No ClinGen
ExAC
gnomAD
rs769155634
CA799364
101 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 102 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA799365
rs776978361
103 Q>H No ClinGen
ExAC
gnomAD
CA339934543
rs1397800360
109 I>T No ClinGen
gnomAD
rs1170062299
CA339934539
109 I>V No ClinGen
gnomAD
rs1338449333
CA339934548
110 N>H No ClinGen
gnomAD
CA799366
rs369786340
110 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA799368
rs773440512
113 W>C No ClinGen
ExAC
gnomAD
CA799369
rs763096971
114 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs751321006
CA799371
116 Q>* No ClinGen
ExAC
gnomAD
rs1339965809
CA339934638
118 L>P No ClinGen
gnomAD
rs754710016
CA799372
120 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA339934655
rs1256109617
121 H>R No ClinGen
gnomAD
CA339934662
rs1171986843
122 G>E No ClinGen
TOPMed
CA339934664
rs1171986843
122 G>V No ClinGen
TOPMed
rs1570322543
CA339934669
123 V>G No ClinGen
Ensembl
CA21226044
rs989553019
123 V>I No ClinGen
gnomAD
CA339934673
rs1213784715
124 P>L No ClinGen
gnomAD
CA799374
rs752573400
130 S>F No ClinGen
ExAC
gnomAD
CA339934722
rs1373948095
131 Y>C No ClinGen
TOPMed
gnomAD
rs1373948095
CA339934721
131 Y>F No ClinGen
TOPMed
gnomAD
rs763184926
CA799386
133 G>R No ClinGen
ExAC
gnomAD
rs1164141686
CA339928281
136 D>E No ClinGen
gnomAD
CA339928301
rs771233628
139 K>I No ClinGen
ExAC
gnomAD
CA799387
rs771233628
139 K>T No ClinGen
ExAC
gnomAD
rs774408102
CA799388
140 M>I No ClinGen
ExAC
gnomAD
CA339928305
rs1557755855
140 M>V No ClinGen
Ensembl
CA339928316
rs1360147107
141 I>T No ClinGen
gnomAD
CA339928313
rs1159293560
141 I>V No ClinGen
gnomAD
rs752196219
CA21184553
CA339928324
142 D>E No ClinGen
Ensembl
rs759444508
CA799389
142 D>N No ClinGen
ExAC
gnomAD
rs1230458125
CA339928352
146 P>L No ClinGen
TOPMed
CA799390
rs767201729
147 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA799392
rs760622156
152 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs758041002
CA21184558
155 S>N No ClinGen
Ensembl
rs1017397440
CA21184560
157 R>* No ClinGen
TOPMed
gnomAD
CA339928424
rs1319334527
158 G>V No ClinGen
gnomAD
rs368983518
CA799394
160 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA799395
rs368983518
160 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA799393
rs141548984
160 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1397289872
CA339928436
161 G>R No ClinGen
gnomAD
TCGA novel 163 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA339928826
rs1375670964
165 F>L No ClinGen
gnomAD
TCGA novel 165 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA21186461
rs994017865
167 A>G No ClinGen
TOPMed
CA799414
rs764596790
169 D>E No ClinGen
ExAC
gnomAD
CA339928878
rs1276580983
169 D>G No ClinGen
gnomAD
CA799415
rs750097478
173 L>F No ClinGen
ExAC
gnomAD
CA339928950
rs1209868650
174 S>Y No ClinGen
gnomAD
rs1341998310
CA339928963
175 D>A No ClinGen
TOPMed
CA799417
rs781563645
176 I>V No ClinGen
ExAC
gnomAD
CA21186480
rs888217881
177 C>* No ClinGen
TOPMed
gnomAD
rs531896186
CA339928995
177 C>S No ClinGen
gnomAD
rs531896186
CA21186477
177 C>Y No ClinGen
gnomAD
rs1437939550
CA339929010
178 H>P No ClinGen
TOPMed
gnomAD
rs1437939550
CA339929008
178 H>R No ClinGen
TOPMed
gnomAD
rs775323132
CA799418
181 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs377484455
CA799419
181 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs771055469
CA799422
186 Y>H No ClinGen
ExAC
gnomAD
rs1397111460
CA339929162
191 Y>C No ClinGen
TOPMed
rs370687403
CA21186489
191 Y>D No ClinGen
ESP
TOPMed
CA799424
rs746132310
192 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1483592081
CA339929197
196 H>R No ClinGen
gnomAD
rs1367932020
CA339929195
196 H>Y No ClinGen
gnomAD
CA799425
rs535993496
198 K>R No ClinGen
ExAC
gnomAD
CA799426
rs535993496
198 K>T No ClinGen
ExAC
gnomAD
rs1309755149
CA339929213
199 D>N No ClinGen
gnomAD
rs373051732
CA799427
200 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs371035515
CA799428
201 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA339929228
rs1257985060
201 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1417198056
CA339929231
202 V>M No ClinGen
Ensembl
CA799430
rs761592786
203 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs1477848333
CA339929253
205 V>A No ClinGen
gnomAD
TCGA novel 205 V>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 207 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA799432
rs772552409
207 G>D No ClinGen
ExAC
gnomAD
CA339929264
rs772552409
207 G>V No ClinGen
ExAC
gnomAD
CA339929267
rs1422745099
208 Q>K No ClinGen
gnomAD
rs762505750
CA339929293
212 S>A No ClinGen
ExAC
TOPMed
gnomAD
CA799434
rs762505750
212 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs1557757690
CA339929303
213 M>I No ClinGen
Ensembl
CA799435
rs766060680
213 M>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA21186524
rs1012321279
213 M>V No ClinGen
TOPMed
gnomAD
rs751209721
CA799436
215 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA799437
rs756531741
215 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs764386461
CA799438
216 C>G No ClinGen
ExAC
gnomAD
rs764386461
CA799439
216 C>R No ClinGen
ExAC
gnomAD
rs757663003
CA799441
221 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs757663003
CA799440
221 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs375631796
CA21186539
221 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
TCGA novel 224 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs745979959
CA799442
225 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA799443
rs758517233
227 S>A No ClinGen
ExAC
gnomAD
rs758517233
CA21186548
227 S>P No ClinGen
ExAC
gnomAD
rs1316667793
CA339929393
228 L>F No ClinGen
gnomAD
rs370287563
CA799445
229 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA799461
rs758606201
231 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA799463
rs536295712
233 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA339929667
rs1262203812
234 K>R No ClinGen
TOPMed
rs1179675270
CA339929678
235 C>G No ClinGen
gnomAD
rs755204576
CA799464
236 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA339929695
rs1381747595
236 P>S No ClinGen
gnomAD
CA799466
rs747937858
238 T>S No ClinGen
ExAC
gnomAD
rs763336933
CA21188181
246 I>M No ClinGen
Ensembl
CA799470
rs770433412
247 Q>* No ClinGen
ExAC
gnomAD
rs773808447
CA799471
248 V>L No ClinGen
ExAC
gnomAD
CA799472
rs759206759
250 N>S No ClinGen
ExAC
gnomAD
CA339929931
rs1239629955
253 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA339930061
rs1202026166
257 C>R No ClinGen
gnomAD
CA799474
rs775173295
260 D>E No ClinGen
ExAC
gnomAD
CA339930120
rs1321135339
260 D>N No ClinGen
TOPMed
rs762148648
CA799475
261 L>F No ClinGen
ExAC
gnomAD
rs765619404
CA339930181
263 I>F No ClinGen
ExAC
TOPMed
gnomAD
CA799476
rs765619404
263 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1439810917
CA339930197
264 M>T No ClinGen
gnomAD
CA799478
rs185643836
265 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA799479
rs766592402
266 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA339930279
rs1173594673
268 S>A No ClinGen
gnomAD
rs1002007701
CA21188228
268 S>Y No ClinGen
TOPMed
CA339930456
rs1397792351
276 A>T No ClinGen
TOPMed
CA339930510
rs1402077683
278 V>A No ClinGen
gnomAD
CA339930697
rs1401072435
287 C>Y No ClinGen
gnomAD
rs1307333634
CA339930731
288 N>S No ClinGen
gnomAD
CA339930754
rs1373549647
290 D>Y No ClinGen
gnomAD
CA21188239
rs35815779
291 V>A No ClinGen
gnomAD
CA339930783
rs1193404341
292 G>C No ClinGen
TOPMed
gnomAD
rs1193404341
CA339930776
292 G>S No ClinGen
TOPMed
gnomAD
CA339930811
rs1330897253
294 I>T No ClinGen
TOPMed
CA339930820
rs1275274669
295 I>V No ClinGen
gnomAD
rs1344066731
CA339930837
296 A>T No ClinGen
gnomAD
CA799484
rs755876389
296 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1168234368
CA339930870
300 M>T No ClinGen
TOPMed
CA799485
rs777559216
304 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA799486
rs144595716
305 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144595716
CA339930898
305 N>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1235968966
CA339930925
308 T>I No ClinGen
TOPMed
gnomAD
CA339930924
rs1235968966
308 T>S No ClinGen
TOPMed
gnomAD
CA339930931
rs1453010006
309 G>E No ClinGen
TOPMed
gnomAD
rs199605892
CA21188255
311 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs984045903
CA21188260
312 A>T No ClinGen
TOPMed
CA799487
rs770805119
313 V>I No ClinGen
ExAC
gnomAD
rs1457338489
CA339930973
316 G>E No ClinGen
gnomAD
rs904688570
CA21188267
317 L>P No ClinGen
gnomAD
CA339930985
rs1465165727
318 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1424986937
CA339930981
318 S>P No ClinGen
TOPMed
gnomAD
CA799489
rs745422365
319 S>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 321 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1392220943
CA339931010
322 E>G No ClinGen
gnomAD
rs771603211
CA799490
323 K>Q No ClinGen
ExAC
TOPMed
gnomAD
CA339931033
rs1230814759
325 E>G No ClinGen
gnomAD
rs34142209
CA799492
325 E>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1279997473
CA339931037
326 P>A No ClinGen
TOPMed
gnomAD
rs199674761
CA799493
326 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA799494
rs199674761
326 P>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 327 D>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 328 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs372150019
CA21188281
329 C>Y No ClinGen
ESP
TOPMed
CA799496
rs150984747
330 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA21188298
rs1015307927
333 Q>R No ClinGen
TOPMed
gnomAD
TCGA novel 334 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752112614
CA799497
336 A>P No ClinGen
ExAC
gnomAD
CA21188306
rs554990152
338 S>G No ClinGen
1000Genomes
CA339931118
rs190498920
339 V>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA799498
rs190498920
339 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA799499
rs375462061
340 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA339931130
rs1196378378
341 T>S No ClinGen
gnomAD
rs1264490166
CA339931143
343 N>D No ClinGen
gnomAD
rs1440340153
CA339931146
343 N>S No ClinGen
TOPMed
rs368593698
CA21188345
344 S>C No ClinGen
ESP
TOPMed
gnomAD
CA21188347
rs994712313
345 G>E No ClinGen
Ensembl
rs1197229338
CA339931167
346 S>F No ClinGen
TOPMed
rs377317775
CA799500
347 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1055055
CA339931185
349 S>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1557759264
CA339931190
350 E>V No ClinGen
Ensembl
CA339931208
rs1310046693
352 E>A No ClinGen
TOPMed
CA799503
rs140250649
355 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs757013970
CA339931231
356 G>E No ClinGen
ExAC
gnomAD
rs112125910
CA21188355
356 G>R No ClinGen
Ensembl
rs757013970
CA799504
356 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA339931241
rs1213438840
358 I>L No ClinGen
gnomAD
rs200652116
CA799506
359 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA799505
rs369934711
359 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs563282299
CA21188372
360 D>G No ClinGen
1000Genomes
gnomAD
CA799508
rs779546982
360 D>N No ClinGen
ExAC
gnomAD
rs149146035
CA799510
365 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA799511
rs776396357
365 T>I No ClinGen
ExAC
gnomAD
rs1472600983
CA339931339
367 G>E No ClinGen
gnomAD
rs878921873
CA21188390
368 A>G No ClinGen
TOPMed
gnomAD
CA339931361
rs878921873
368 A>V No ClinGen
TOPMed
gnomAD
rs760358762 369 P>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA799514
rs771409634
371 S>Y No ClinGen
ExAC
gnomAD
CA799515
rs775012834
372 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs377006477
CA21188394
374 P>L No ClinGen
TOPMed
gnomAD
rs760022684
CA799516
374 P>S No ClinGen
ExAC
gnomAD
CA799519
rs369104105
375 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369104105
CA799520
375 E>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1421801193
CA339931486
376 P>R No ClinGen
gnomAD
CA339931481
rs1366900646
376 P>S No ClinGen
gnomAD
CA339931492
rs1159493708
377 G>R No ClinGen
gnomAD
CA339931490
rs1159493708
377 G>S No ClinGen
gnomAD
CA799522
rs757097592
379 N>H No ClinGen
ExAC
gnomAD
rs764950757
CA799526
380 I>M No ClinGen
ExAC
rs1033483392
CA799524
380 I>V No ClinGen
TOPMed
gnomAD
CA339931631
rs1396076884
381 N>S No ClinGen
gnomAD
rs888276297
CA21188413
382 N>K No ClinGen
TOPMed
CA339931752
rs1165194640
385 A>T No ClinGen
gnomAD
rs1241818443
CA339931895
390 L>F No ClinGen
gnomAD
rs1287736484
CA339931932
391 K>N No ClinGen
TOPMed
rs779836204
CA799529
391 K>Q No ClinGen
ExAC
gnomAD

No associated diseases with Q8IXN7

2 regional properties for Q8IXN7

Type Name Position InterPro Accession
domain ATP-grasp fold 115 - 300 IPR011761
domain ATP-grasp fold, RimK-type 110 - 297 IPR013651

Functions

Description
EC Number 6.3.2.41 Acid--amino-acid ligases (peptide synthases)
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ligase activity, forming carbon-nitrogen bonds Catalysis of the joining of two molecules, or two groups within a single molecule, via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.
metal ion binding Binding to a metal ion.
N-acetyl-L-aspartate-L-glutamate ligase activity Catalysis of the reaction: ATP + N-acetyl-L-aspartate + L-glutamate = ADP + phosphate + N-acetylaspartyl-glutamate.

2 GO annotations of biological process

Name Definition
glutamine family amino acid metabolic process The chemical reactions and pathways involving amino acids of the glutamine family, comprising arginine, glutamate, glutamine and proline.
protein modification process The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q0VCE9 RIMKLB Beta-citrylglutamate synthase B Bos taurus (Bovine) PR
Q9ULI2 RIMKLB Beta-citrylglutamate synthase B Homo sapiens (Human) PR
Q80WS1 Rimklb Beta-citrylglutamate synthase B Mus musculus (Mouse) PR
Q6PFX8 Rimkla N-acetylaspartylglutamate synthase A Mus musculus (Mouse) PR
10 20 30 40 50 60
MCSQLWFLTD RRIREDYPQV QILRALRQRC SEQDVRFRAV LMDQIAVTIV GGHLGLQLNQ
70 80 90 100 110 120
KALTTFPDVV LVRVPTPSVQ SDSDITVLRH LEKLGCRLVN RPQSILNCIN KFWTFQELAG
130 140 150 160 170 180
HGVPMPDTFS YGGHEDFSKM IDEAEPLGYP VVVKSTRGHR GKAVFLARDK HHLSDICHLI
190 200 210 220 230 240
RHDVPYLFQK YVKESHGKDI RVVVVGGQVI GSMLRCSTDG RMQSNCSLGG VGVKCPLTEQ
250 260 270 280 290 300
GKQLAIQVSN ILGMDFCGID LLIMDDGSFV VCEANANVGF LAFDQACNLD VGGIIADYTM
310 320 330 340 350 360
SLLPNRQTGK MAVLPGLSSP REKNEPDGCA SAQGVAESVY TINSGSTSSE SEPELGEIRD
370 380 390
SSASTMGAPP SMLPEPGYNI NNRIASELKL K